Loading viewer...
investor_presentation
Format: PDF investor_presentation
This investor presentation by AIM ImmunoTech outlines forward-looking statements regarding Ampligen® and its potential in treating various diseases as of Q1 2023.
presentation
investor_presentation
17 Pages
Tenaga Nasional Berhad
Home First Finance Q4 FY24 Investor Presentation 2024
investor_presentationinvestor_presentation
49 Pages
Home First Finance Company India Limited